Patent Publication Number: US-6217856-B1

Title: Symmetrical triazine derivatives

Description:
This application is a 371 of PCT/EP97/06226 filed Nov. 10, 1997. 
    
    
     The present invention relates to symmetrical triazine derivatives, to the preparation of these compounds as well as to their use for protecting organic materials from the harmful effects of UV radiation. 
     O-alkylated o-hydroxyphenyltriazines (HPT) containing at least one o-hydroxyl group or at least two alkoxyphenyl substituents are known, e.g. from EP-A-0,743,309, as cosmetic UV absorbers having good spectral properties and good technical application properties. However, the preparation of such triazine derivatives, which are derived from the unsymmetrical basic structure                    
     requires multistep synthesis processes. 
     In the above formula, R a  and R b  are a reactive radical, in particular a phenyl radical which is mono- or polysubstituted by hydroxyl groups. 
     Symmetrical triazine compounds which may be prepared from the symmetrical basic structure                    
     are easier to access in simple one-bach processes. 
     Such “triazine basic structures” may be prepared, for example, by trimerising corresponding benzonitrile compounds or, starting from cyanuric chloride, by Grignard reaction or Friedel-Crafts alkylation. Subsequent etherification of the free OH groups makes it possible to prepare the desired triazine derivatives may be prepared in a two-step reaction. 
     Accordingly, this invention relates to symmetrical triazine derivatives of formula                    
     wherein 
     R 1  and R 2  are each independently of the other hydrogen; C 1 -C 12 alkyl; or C 1 -C 12 alkoxy; and R 3  is C 1 -C 12 alkyl; or C 1 -C 12 alkoxy. 
     C 1 -C 12 Alkyl or C 1 -C 12 alkoxy are straight-chain or branched alkyl radicals, typically methyl, ethyl, n-propyl, isopropyl, n-butyl, sec-butyl, tert-butyl, amyl, isoamyl or tert-amyl, heptyl, octyl, isooctyl, nonyl, decyl, undecyl or dodecyl, or methoxy, ethoxy, propoxy, butoxy, pentyloxy, hexyloxy, heptyloxy, octyloxy, nonyloxy, decyloxy, undecyloxy or dodecyloxy. 
     Particularly preferred compounds are those of formula (1), wherein 
     R 3  is C 1 -C 12 alkoxy, in particular C 5 -C 12 alkoxy; and 
     R 1  and R 2  have the meaning given in formula (1). 
     Very particularly preferred compounds are those conforming to formula                    
     wherein 
     R 4  and R 5  are each independently of the other hydrogen; C 1 -C 12 alkyl; or C 1 -C 12 alkoxy; and 
     R 6  is C 1 -C 12 alkyl; or C 1 -C 12 alkoxy. 
     Important compounds are, in particular, those of formula (2), wherein 
     R 4  is hydrogen; and 
     R 5  and R 6  are C 5 -C 12 alkoxy; 
     or those compounds of formula (2), wherein 
     R 4  and R 5  are C 5 -C 12 alkyl; and 
     R 6  is hydrogen. 
     Very particularly preferred compounds are those of formula                    
     wherein 
     R 7  is C 5 -C 12 alkoxy; and 
     R 8  is hydrogen; or C 1 -C 5 alkyl. 
     The triazine derivatives of this invention can be used as single compounds or as mixtures of different single compounds with each other. 
     The novel symmetrical triazine derivatives of formula (1) can, in particular, also be used as mixtures with triazine compounds of formula                    
     In formula (4), 
     R 10  is hydrogen; C 6 -C 12 alkyl; or C 2 -C 6 alkenyl; and 
     R 11  is C 1 -C 12 alkoxy. 
     C 2 -C 6 Alkenyl is, for example, allyl, methallyl, isopropenyl, 2-butenyl, 3-butenyl, isobutenyl, n-penta-2,4-dienyl or 3-methyl-but-2-enyl. 
     The mixtures of triazine compounds of formula (1) and formula (4) are another subject matter of this invention. 
     The novel triazine derivatives of formula (1) may be prepared in different manner. In a Grignard reaction, for example, 1 mol of cyanuric chloride is reacted with 3 mol of the corresponding phenylmagnesium bromide compound which, depending on the meaning of R 1 , R 2  and R 3  of formula (1), may contain an alkyl radical and/or one or several free hydroxyl groups. Processes for the preparation of this intermediate are known and are described, inter alia, in EP-A-0,557,559. 
     This intermediate is also obtainable by Friedel-Crafts alkylation of cyanuric chloride with the corresponding phenyl compounds which, depending on the meaning of R 1 , R 2  and R 3  in formula (1), may contain an alkyl radical and/or one or several free hydroxyl groups, in the presence of a Lewis acid, preferably aluminium chloride. 
     According to A. Ninagawa, M. Kawazoe, H. Matsuada, Makromol.Chem. 180, (1979), 2123, this intermediate is also obtainable by cyclotrimerisation of a benzonitrile compound containing an alkyl radical and/or one or more than one hydroxyl group, depending on the meaning of R 1 , R 2  and R 3  in formula (1). 
     The end products corresponding to formula (1) are obtainable in a second reaction step by etherifying the hydroxyl group of the intermediates obtained in the first reaction step by alkylation in accordance with customary methods. 
     A further subject matter of this invention relates to the processes for the preparation of the novel triazine derivatives. 
     The inventive symmetrical triazine derivatives of formula (1) or mixtures of these compounds with triazine compounds of formula (4) as well as compounds of formula                    
     wherein 
     Ar is a radical of formula                    
      R 1 is hydrogen; hydroxy; C 1 -C 12 alkyl; or C 1 -C 12 alkoxy; 
     R 2  is hydroxy; C 1 -C 12 alkoxy; or benzyloxy; 
     R 3  is hydroxy; C 1 -C 12 alkyl; or C 1 -C 12 alkoxy; and 
     R 4  is hydrogen; or C 1 -C 12 alkoxy; or 
     R 1  and R 2 , together with the phenyl radical, are a heterocyclic five-membered ring which is condensed with benzene, preferably a radical of formula (5a)                    
     are particularly suitable as UV filters, i.e. for protecting ultraviolet-sensitive organic materials, in particular the skin and hair of humans and animals, against the harmful effects of UV radiation. 
     Illustrative examples of compounds of formula (5) are                                      
     Accordingly, these compounds are suitable as light stabilisers in cosmetic, pharmaceutical and veterinary preparations. They can be obtained in dissolved form or, it they are only sparingly soluble or insoluble, they can be incorporated in the preparations in micronised form having an average particle size in the range of 0.02 to 2, preferably of 0.05 to 1.5 and, most preferably, of 0.1 to 1.0 μm. 
     Accordingly, another object of this invention is the provision of a cosmetic preparation for skin or hair, which comprises at least one compound of formula (1) or (5) as well as carriers or auxiliaries which are cosmetically compatible with skin and hair, or to a cosmetic formulation for skin or hair, which comprises a mixture of 
     a) at least one or more than one compound of formula (1) or (5), and 
     b) a compound of formula (4) 
     together with carriers or auxiliaries which are cosmetically compatible with skin and hair. 
     In addition to the novel UV absorbers, the cosmetic formulations can also contain one or more than one further UV protective of the following substance classes: 
     1. p-aminobenzoic acid derivatives, typically 2-ethylhexyl 4-dimethylaminobenzoate; 
     2. salicylic acid derivatives, typically 2-ethylhexyl salicylate; 
     3. benzophenone derivatives, typically 2-hydroxy-4-methoxybenzophenone and its 5-sulfonic acid derivative; 
     4. dibenzoylmethane derivatives, typically 1-(4-tert-butylphenyl)-3-(4-methoxyphenyl)-propane-1,3-dione; 
     5. diphenylacrylates, typically 2-ethylhexyl-2-cyano-3,3-diphenylacrylate and 3-(benzo-furanyl)-2-cyanoacrylate; 
     6. 3-imidazol-4-yl-acrylic acid and 3-imidazol-4-yl-acrylate; 
     7. benzofuran derivatives, preferably 2-(p-aminophenyl)benzofuran derivatives, disclosed in EP-A-582,189, U.S. Pat. No. 5,338,539, U.S. Pat. No. 5,518,713 and in EP-A-613,893; 
     8. polymeric UV absorbers, such as the benzylidenemalonate derivatives described, inter alia, in EPA-709,080; 
     9. cinnamic acid derivatives, typically the 2-ethylhexyl 4-methoxycinnamate or isoamylate or cinnamic acid derivatives disclosed, inter alia, in U.S. Pat. No. 5,601,811 and WO 97/00851; 
     10. camphor derivatives, typically 3-(4′-methyl)benzylidenebornan-2-one, 3-benzylidene-bornan-2-one, N-[2(and 4)-2-oxyborn-3-ylidenemethyl)benzyl]acrylamide polymer, 3-(4′-trimethylammonium) benzylidenebornan-2-one methyl sulfate, 3,3′-(1, 4-phenylenedime-thine)-bis (7,7-dimethyl-2-oxo-bicyclo-[2.2.1]heptane-1-methansulfonic acid) and the salts thereof, 3-(4′-sulfo)benzylidenebornan-2-one and the salts thereof; 
     11. trianilino-s-triazine derivatives, typically 2,4,6-trianiline-(p-carbo-2′-ethyl-1′-oxi)-1,3,5-triazines as well as the UV absorbers disclosed in U.S. Pat. No. 5,332,568, EP-A-517,104, EP-A-507,691, WO 93/17002 and EP-A-570,838; 
     12. 2-hydroxyphenylbenzotriazole derivatives; 
     13. 2-phenylbenzimidazole-5-sulfonic acid and the salts thereof; 
     14. menthyl-o-aminobenzoate; 
     15. TiO 2  (coated differently), ZnO and mica. 
     The UV absorbers described in “Sunscreens”, Eds. N. J. Lowe, N. A.Shaath, Marcel Dekker, Inc., New York and Basel or in Cosmetics &amp; Toiletries (107), 50 et seq. (1992), can also be used as additional UV protectives in the inventive formulations. 
     The cosmetic formulations can also be used together with known antioxidants, such as vitamin E, carotinoids or HALS compounds. 
     The novel cosmetic formulations usually comprise 0.1 to 25, preferably 0.5 to 10%, by weight, based on the total weight of the formulation, of a UV absorber of formula (1) or (5) or of a mixture of UV absorbers of formula (1) and formula (4) and a cosmetically compatible auxiliary. 
     The cosmetic formulations can be prepared by physically mixing the UV absorber(s) with the auxiliaries by conventional methods, such as by simply stirring the individual components together. 
     The cosmetic formulations of this invention can be formulated as water-in-oil or oil-in-water emulsion, as oil-in-alcohol lotion, as vesicular dispersion of a ionic or nonionic amphiphilic lipid, as gel, solid stick or as aerosol formulation. 
     As water-in-oil or oil-in-water emulsion, the cosmetically compatible auxiliary preferably comprises 5 to 50% of an oil phase, 5 to 20% of an emulsifier and 30 to 90% of water. The oil phase can contain any oil suitable for cosmetic formulations, for example one or several hydrocarbon oils, wax, natural oil, silicone oil, fatty acid ester or fatty alcohol. Preferred mono- or polyols are ethanol, isopropanol, propylene glycol, hexylene glycol, glycerol and sorbitol. 
     Cosmetic formulations for hair can be present 
     in the form of a shampoo, lotion, gel or emulsion for rinsing, before or after shampooing, before or after dyeing or removing dye, before or after a perming or straightening process, 
     in the form of a lotion, foam or gel for setting or treating hair, 
     in the form of a lotion or gel for brushing or waving hair, 
     in the form of a hair lacquer, 
     in the form of a composition for perming or straightening hair, for dyeing or removing dye. 
     It is possible to use, for example, the following cosmetic formulations for hair: 
     a 1 ) spontaneously emulsifying stock formulations, consisting of the UV absorber, PEG-6 C 10 oxoalcohol and sorbitan esquioleate, which is charged with water and any quaternary ammonium compound, such as 4% minkamidopropyidimethyl-2-hydroxyethyl ammonium chloride or Quaternium 80; 
     a 2 ) spontaneously emulsifying stock formulation, consisting of the UV absorber, tributyl citrate and PEG-20 sorbitan monooleate, which is charged with water and any quaternary ammonium compound, such as 4% minkamidopropyldimethyl-2-hydroxyethyl ammonium chloride or Quaternium 80; 
     b) quat-doped solutions of the UV absorber in butyl triglycol and tributyl citrate; 
     c) dispersions of micronised UV absorbers obtained by known methods (precipitation from solutions or mixtures of solutions, grinding), having an average diameter of 0.05-1.0 μm in APG (e.g. Plantaren), and a quat (e.g. minkamidopropyldimethyl-2-hydroxyethyl ammonium chloride) in an aqueous formulation; 
     d) mixtures or solutions of the UV absorber with n-alkylpyrrolidone. 
     The cosmetic formulations for skin or hair may also contain other components, such as emollients, emulsion stabilisers, skin moisturisers, suntan promoters, thickeners, such as xanthan, moisture retention agents, such as glycerol, preservatives, fragrances and colourants. 
     The novel cosmetic formulations for skin or hair are distinguished by excellently protecting human skin and hair against the harmful effects of sunlight. 
    
    
     The following non-limitative Examples illustrate the invention in more detail. Percentages are by weight. 
     EXAMPLE 1 
     Preparation of 2,4,6-tris(4-2-ethylhexyloxyphenyl)-(1,3,5)-triazine 
     
       
         
         
             
             
         
       
     
     The basic structure of formula                    
     is prepared by cyclotrimerising p-hydroxybenzonitrile according to A. Ninagawa, M. Kawazoe, H. Matsuda, Makromol. Chem. 180 (1979), 2123. 
     5.36 g of the compound of formula (101a) are dissolved in 50 ml of dimethylformamide (DMF) and are charged with 6.53 g of finely powdered potassium carbonate at 100-105° C. This mixture is stirred for 30 minutes and then 8.23 g of 3-(chloromethyl)heptane, dissolved in 10 ml of DMF, are added dropwise over another 30 minutes at 100-105° C. The temperature is slowly elevated to 135° C. over 6 hours. After cooling to 100° C., 50 ml of toluene are added and the precipitated salts are removed by filtration. The filtrate is concentrated to dryness by evaporation and the residue is taken up with 50 ml of toluene and 100 ml of water, acidified and extracted by shaking. The dried organic phase is concentrated by evaporation. The crude product (c. 7 g) is purified by column chromatography (silica gel, cyclohexane/toluene 7:3). 
     Yield: 4.8 g of colourless oil (46% of theory). 
     EXAMPLE 2 
     Preparation of 2,4,6-tris[3,5-dimethyl-4-(2-ethylhexyloxyphenyl)-(1,3,5)-triazine 
     
       
         
         
             
             
         
       
     
     The basic structure of formula (102a)                    
     is obtained, for example, by reacting 2,6-dimethylphenol with cyanuric chloride under Friedel-Crafts conditions (cf DE-A-2,219,012). 
     6.62 g of the compound of formula (102a) are dissolved in 70 ml of dimethylformamide and are charged with 6.53 g of finely powdered potassium carbonate at 100-105° C. This mixture is stirred for 30 minutes and then 11.65 g of 3-(chloromethyl)heptane, dissolved in 10 ml of DMF, are added dropwise over another 60 minutes at 100-105° C. The temperature is kept at 100-105° C. for 3 hours. After cooling to 100° C., 50 ml of toluene are added and the precipitated salts are removed by filtration. The filtrate is concentrated to dryness by evaporation and the residue is charged with 100 ml of toluene and 100 ml of water, acidified and extracted by shaking. The organic phase is washed with water until neutral, separated, dried and concentrated by evaporation. The crude product (c. 10 g) is purified by column chromatography (silica gel, cyclohexane/toluene 65:35). 
     Yield: 4.7 g of colourless crystals, m.p. 83-84° C., (40% of theory). 
     EXAMPLE 3 
     The compounds of formula                    
     can be prepared in general analogy to the procedure of Example 1. 
     USE EXAMPLES 
     EXAMPLE 4 
     Preparation of an O/W emulsion 
     Formulation (names according to CTFA or INCl): 
     
       
         
           
               
               
               
               
             
               
                   
                   
               
             
            
               
                   
                 (a 1 ) 
                 ceteareth 6 (and) stearyl alcohol 
                 2.0% 
               
               
                   
                 (a 2 ) 
                 ceteareth 25 
                 2.0% 
               
               
                   
                 (a 3 ) 
                 cetearyl alcohol 
                 5.0% 
               
               
                   
                 (a 4 ) 
                 caprylic/capric triglyceride 
                 5.0% 
               
               
                   
                 (a 5 ) 
                 cetearyl octanate 
                 10.0% 
               
               
                   
                 (a 6 ) 
                 Vaseline 
                 5.0% 
               
               
                   
                 (a 7 ) 
                 compound of formula (101) 
                 4.0% 
               
               
                   
                 (b 1 ) 
                 propylene glycol 
                 3.0% 
               
               
                   
                 (b 2 ) 
                 carbopol 934 
                 0.2% 
               
               
                   
                 (b 3 ) 
                 H 2 O 
                 63.53% 
               
               
                   
                 (c) 
                 triethanol amine 
                 0.27% 
               
               
                   
                   
               
            
           
         
       
     
     Components (a 1 )-(a 7 ) (=phase A) and (b 1 )-(b 3 ) (=phase B) are heated to 75-80° C. Phase B is then added to phase A and homogenised. Component (c) (=phase C) is then added and again homogenised. 
     The sunscreen factors are determined by the method of Diffey and Robson, J. Soc. Cosmet. Chem. 40, 127-133 (1989) using an SPF (sunproof factor) analyser (Optometrix, SPF 290). 
     This O/W emulsion has a sunscreen factor of 7.8. 
     EXAMPLE 5 
     Preparation of a Suntan Cream 
     Formulation (the individual components are named according to CTFA or INCl): 
     
       
         
           
               
             
               
                   
               
               
                 Phase A: 
               
               
                   
               
             
            
               
                   
               
            
           
           
               
               
               
               
            
               
                   
                 (a 1 ) 
                 dimethicone 
                 2.0% 
               
               
                   
                 (a 2 ) 
                 isopropyl myristate 
                 9.0% 
               
               
                   
                 (a 3 ) 
                 stearyl alcohol 
                 10.0% 
               
               
                   
                 (a 4 ) 
                 stearic acid 
                 4.0% 
               
               
                   
                 (a 5 ) 
                 compound of formula (102) 
                 4.0% 
               
               
                   
                 (a 6 ) 
                 micronised 2,4-bis(phenyl)-6-(2-hydroxy-4- 
                 3.2% 
               
               
                   
                   
                 methoxyphenyl)-(1,3,5)-triazine (Ø 0.25 μm) 
               
               
                   
                 (b 1 ) 
                 triethanol amine 
                 1.2% 
               
               
                   
                 (b 2 ) 
                 carbomer 934 (1%) 
                 5.0% 
               
               
                   
                 (b 3 ) 
                 H 2 O 
                 61.6% 
               
               
                   
                   
               
            
           
         
       
     
     Components (a 1 -a 6 ) (=phase A) are homogenised separately and very carefully and are then, like components (b 1 )-(b 3 ) (=phase B), heated separately to 75-80° C. Phase B is then added to phase A with vigorous stirring. With stirring, the mixture is allowed to cool. 
     This suntan cream has a sunscreen factor of 11.